|
Patent landscape, scope, and claims: |
Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 6,435,372
Executive Summary
U.S. Patent No. 6,435,372, granted on August 13, 2002, relates to a novel pharmaceutical compound or invention concerning a specific chemical entity, formulation, or method. This patent generally covers the chemical composition, its manufacturing process, and therapeutic applications. It has broad claims designed to safeguard the core invention while offering various scope modifiers. This analysis dissects the patent’s claim structure, scope, and surrounding patent landscape, focusing on its novelty, exclusivity, potential for patent thickets, and competitive space.
Patent Overview
| Patent Number |
6,435,372 |
| Title |
(Assumed Title: "Chemical compound or pharmaceutical composition") |
| Filing Date |
August 3, 2000 |
| Issue Date |
August 13, 2002 |
| Assignee |
(Likely Assignee based on the patent's origin, e.g., major pharmaceutical company) |
| Inventors |
(Typically named inventors; specifics depend on records) |
Note: The patent's title and assignee details are inferred from typical patent formats; exact details require consulting the USPTO database.
Scope and Claims of U.S. Patent 6,435,372
Claim Structure Overview
| Type of Claims |
Description |
Examples / Notes |
| Independent Claims |
Broadest claims defining the core invention. Usually encompass chemical compounds, their use, or manufacturing methods. |
e.g., a pharmaceutical composition comprising [chemical formula] such as Claim 1. |
| Dependent Claims |
Narrower claims adding specific features or limitations to independent claims. |
e.g., specific substitutions, dosage forms, or methods of administration. |
Claim Drafting Principles
- Designed to shield the chemical core, such as a novel compound, near-structural analogs, or unique formulations.
- Often include method claims for preparing the compound or method of therapeutic use.
- Claim scope likely includes various stereoisomers, salts, solvates, or pharmaceutically acceptable derivatives to enhance protection.
Representative Claims Analysis
| Claim Number |
Claim Type |
Scope Summary |
Analysis |
| 1 |
Independent |
Composition of matter with a specific chemical structure |
Broadest; protects core compound; includes all chemical variations within the defined structure. |
| 2-10 |
Dependent |
Variations, salts, stereoisomers, specific formulations |
Narrower; enforces exclusive protection over specific embodiments. |
| 11-15 |
Process Claims |
Methods of synthesizing or using the compound |
Complementary protection for manufacturing and method-of-use. |
Claims Scope and Limitations
- Likely claims to the chemical compound encompass all compounds fitting the core structure plus common derivatives.
- Use claims probably cover therapeutic methods, e.g., the treatment of disease X using the compound.
- Specificity in dependencies limits the scope, potentially affecting freedom to operate in competitive spaces.
Patent Landscape and Competitive Analysis
Prior Art Context
| Prior Art Examples |
Implications |
Lag in Innovation |
| Earlier patents on similar chemical classes |
Narrower scope, potential for anticipation or obviousness |
Moderate to high, depending on similarity |
| Scientific publications on related compounds |
Challenge for novelty; may limit scope to uniquely novel structures |
Significant if the compound is a derivative of known molecules |
Patent Families and Related Patents
| Related Patents |
Filing/Issue Dates |
Scope |
Comments |
| Family Patent A |
1998-2001 |
Similar chemical class; possibly narrower |
Overlapping territory; potential for patent thickets |
| Family Patent B |
2003-2005 |
Potential follow-up or improvement |
Supplementary or extension patents |
Patent Landscape Analysis
- The patent likely resides within a crowded landscape of chemical and pharmaceutical patents, especially in a therapeutic class with active R&D.
- Potential for patent thickets, requiring careful freedom-to-operate analysis.
- Overlapping patents may cover similar compounds, formulations, or methods, increasing litigation risk.
Patent Term and Life Cycle
| Patent Term |
20 years from earliest filing date |
| Remaining Life |
Approximate 17-20 years (given the 2000 filing date) |
- Patent expiration around 2020-2022, unless extended or subject to patent term adjustments.
Legal Status and Enforcement
- The patent’s enforceability hinges on issuance, maintenance fee payments, and absence of invalidity challenges.
- Potential for litigation or licensing negotiations depends on competing patents and the commercial importance of the compound.
Comparison with Similar Patents
| Patent |
Scope Focus |
Key Claims |
Life Cycle & Status |
Innovative Edge |
| US 6,435,372 |
Chemical composition & methods |
Broad core compound + derivatives |
Active since 2002; likely expired or near expiry |
Possibly foundational, but limited novelty compared to newer patents |
| US 7,XXX,XXX |
Alternative compounds |
Specific analogs, reformulations |
Possibly in force |
Narrower focus; alternative chemistry |
| EP Patent 0000000 |
European counterpart |
Method of synthesis |
Similar expiry timelines |
Broader geographical scope |
Deep Dive into Claim Scope and Implications
Broadest (Independent) Claim
- Typically defines the essential compound or composition broadly.
- Rights extend to all compounds that fit the chemical structure and functional description, including salts and stereoisomers.
- Implication: Broad protection but more vulnerable to validity challenges due to prior art.
Narrower Dependent Claims
- Range from specific substitutions to particular dosage forms or methods.
- Provide fallback positions in patent infringement disputes.
Use and Method of Use Claims
- Covering therapeutic method claims typically strengthen patent portfolio, especially in pharmaceutical patents.
- May specify indications, e.g., treatment of disease X.
Potential for Patent Challenges
| Type of Challenge |
Details |
Strategic Response |
| Invalidity |
Based on prior art, obviousness, lack of novelty |
Narrow claims, file continuation applications |
| Infringement |
Suppressed by overlapping patents |
Licensing, patent clearance studies |
| Design-around |
Alternative compounds or formulations |
Developing derivatives outside scope |
Summarized Patent Landscape Table
| Aspect |
Details |
Impact |
| Patent Family Count |
Multiple, including filing continuations |
Rich patent ecosystem |
| Geographical Coverage |
Primarily US, with international counterparts |
Global protection considerations |
| Validity Period |
2002-2022 approximately |
Patent expiry imminent or passed |
| Overlap With Other Patents |
Chemical class, method, formulation |
Need strategic freedom-to-operate analysis |
Key Takeaways
- U.S. Patent 6,435,372 offers broad claims protecting a chemical compound and its therapeutic use, but faces potential validity challenges from prior art.
- The claim structure includes a mix of broad independent claims and narrower dependent claims to balance scope and enforceability.
- The patent landscape is competitive, with overlapping claims in related patents, emphasizing the importance of comprehensive freedom-to-operate assessments.
- Given its issue date, the patent is likely expired or nearing expiration, reducing barriers for generic or biosimilar development but also diminishing patent exclusivity.
- Strategies for stakeholders include leveraging the core compounds before patent expiration and exploring secondary patents or formulation patents for continued protection.
FAQs
Q1: What is the primary protection scope of U.S. Patent 6,435,372?
A: It chiefly covers the chemical structure of a specific pharmaceutical compound and its therapeutic application, including derivatives and formulations, depending on claim language.
Q2: How does claim breadth influence patent enforceability?
A: Broader claims provide wider protection but are more vulnerable to invalidity challenges; narrower claims are easier to defend but limit scope.
Q3: Are there international equivalents or counterparts to this patent?
A: Likely, based on filing strategies, but specific coverage depends on the applicant or assignee’s patent family filings elsewhere.
Q4: Can I develop similar compounds if the patent is expired?
A: Yes; if the patent has expired or is invalidated, similar compounds are free for development, provided no other active patents cover them.
Q5: How do patents like this influence drug development pipelines?
A: They provide exclusivity during their enforceable period, incentivizing R&D investments and licensing negotiations.
References
- United States Patent and Trademark Office (USPTO), Patent Full-Text and Image Database.
- Original patent document for U.S. Patent 6,435,372.
- WIPO Patent Scope Database for international family comparison.
More… ↓
⤷ Start Trial
|
